Report Detail

Service & Software Global Hereditary Disease Testing Market 2026 by Company, Regions, Type and Application, Forecast to 2032

  • RnM4763231
  • |
  • 29 October, 2026
  • |
  • Global
  • |
  • 114 Pages
  • |
  • GIR
  • |
  • Service & Software

According to our (Global Info Research) latest study, the global Hereditary Disease Testing market size was valued at US$ 1185 million in 2025 and is forecast to a readjusted size of US$ 2600 million by 2032 with a CAGR of 12.0% during review period.
Hereditary disease testing is a medical detection method that analyzes an individual’s genetic material (DNA, RNA, or chromosomes) to identify genetic variations associated with inherited diseases. It helps assess disease risk, diagnose conditions, or guide prevention and treatment.
The global market for hereditary disease testing is experiencing rapid growth, driven by factors such as technological advancements, increased awareness of genetic diseases, and the expansion of personalized medicine.
North America has the largest market share in the global hereditary disease testing market. This is because of its advanced healthcare infrastructure, high - level medical technology, and strong awareness of hereditary diseases among the population. For example, the United States has a large number of leading genetic testing companies and research institutions.
Asia - Pacific is the region with the fastest - growing market. Driven by the continuous increase in healthcare investments and the active promotion of genomic research in countries such as China and India, the market demand is constantly expanding.
This report is a detailed and comprehensive analysis for global Hereditary Disease Testing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Hereditary Disease Testing market size and forecasts, in consumption value ($ Million), 2021-2032
Global Hereditary Disease Testing market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Hereditary Disease Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Hereditary Disease Testing market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Hereditary Disease Testing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Hereditary Disease Testing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Myriad Genetics, Invitae, Illumina, Natera, Laboratory Corporation of America Holdings, F. Hoffmann-La Roche, Quest Diagnostics, CooperSurgical, Agilent Technologies, Thermo Fisher Scientific, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Hereditary Disease Testing market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Hereditary Cancer Testing
Hereditary Non-cancer Testing
Market segment by Testing Content
Chromosomal Testing
Gene Mutation Testing
Genome/Exome Sequencing
Carrier Screening Panels
Market segment by Detection Object
Aldult
Child
Market segment by Application
Hospital
Clinic
Laboratory
Others
Market segment by players, this report covers
Myriad Genetics
Invitae
Illumina
Natera
Laboratory Corporation of America Holdings
F. Hoffmann-La Roche
Quest Diagnostics
CooperSurgical
Agilent Technologies
Thermo Fisher Scientific
Twist Bioscience
Sophia Genetics
Fulgent Genetic
Medgenome
CENTOGENE
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Hereditary Disease Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Hereditary Disease Testing, with revenue, gross margin, and global market share of Hereditary Disease Testing from 2021 to 2026.
Chapter 3, the Hereditary Disease Testing competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Hereditary Disease Testing market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Hereditary Disease Testing.
Chapter 13, to describe Hereditary Disease Testing research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Hereditary Disease Testing by Type
    • 1.3.1 Overview: Global Hereditary Disease Testing Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Hereditary Disease Testing Consumption Value Market Share by Type in 2025
    • 1.3.3 Hereditary Cancer Testing
    • 1.3.4 Hereditary Non-cancer Testing
  • 1.4 Classification of Hereditary Disease Testing by Testing Content
    • 1.4.1 Overview: Global Hereditary Disease Testing Market Size by Testing Content: 2021 Versus 2025 Versus 2032
    • 1.4.2 Global Hereditary Disease Testing Consumption Value Market Share by Testing Content in 2025
    • 1.4.3 Chromosomal Testing
    • 1.4.4 Gene Mutation Testing
    • 1.4.5 Genome/Exome Sequencing
    • 1.4.6 Carrier Screening Panels
  • 1.5 Classification of Hereditary Disease Testing by Detection Object
    • 1.5.1 Overview: Global Hereditary Disease Testing Market Size by Detection Object: 2021 Versus 2025 Versus 2032
    • 1.5.2 Global Hereditary Disease Testing Consumption Value Market Share by Detection Object in 2025
    • 1.5.3 Aldult
    • 1.5.4 Child
  • 1.6 Global Hereditary Disease Testing Market by Application
    • 1.6.1 Overview: Global Hereditary Disease Testing Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.6.2 Hospital
    • 1.6.3 Clinic
    • 1.6.4 Laboratory
    • 1.6.5 Others
  • 1.7 Global Hereditary Disease Testing Market Size & Forecast
  • 1.8 Global Hereditary Disease Testing Market Size and Forecast by Region
    • 1.8.1 Global Hereditary Disease Testing Market Size by Region: 2021 VS 2025 VS 2032
    • 1.8.2 Global Hereditary Disease Testing Market Size by Region, (2021-2032)
    • 1.8.3 North America Hereditary Disease Testing Market Size and Prospect (2021-2032)
    • 1.8.4 Europe Hereditary Disease Testing Market Size and Prospect (2021-2032)
    • 1.8.5 Asia-Pacific Hereditary Disease Testing Market Size and Prospect (2021-2032)
    • 1.8.6 South America Hereditary Disease Testing Market Size and Prospect (2021-2032)
    • 1.8.7 Middle East & Africa Hereditary Disease Testing Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Myriad Genetics
    • 2.1.1 Myriad Genetics Details
    • 2.1.2 Myriad Genetics Major Business
    • 2.1.3 Myriad Genetics Hereditary Disease Testing Product and Solutions
    • 2.1.4 Myriad Genetics Hereditary Disease Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Myriad Genetics Recent Developments and Future Plans
  • 2.2 Invitae
    • 2.2.1 Invitae Details
    • 2.2.2 Invitae Major Business
    • 2.2.3 Invitae Hereditary Disease Testing Product and Solutions
    • 2.2.4 Invitae Hereditary Disease Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Invitae Recent Developments and Future Plans
  • 2.3 Illumina
    • 2.3.1 Illumina Details
    • 2.3.2 Illumina Major Business
    • 2.3.3 Illumina Hereditary Disease Testing Product and Solutions
    • 2.3.4 Illumina Hereditary Disease Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Illumina Recent Developments and Future Plans
  • 2.4 Natera
    • 2.4.1 Natera Details
    • 2.4.2 Natera Major Business
    • 2.4.3 Natera Hereditary Disease Testing Product and Solutions
    • 2.4.4 Natera Hereditary Disease Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Natera Recent Developments and Future Plans
  • 2.5 Laboratory Corporation of America Holdings
    • 2.5.1 Laboratory Corporation of America Holdings Details
    • 2.5.2 Laboratory Corporation of America Holdings Major Business
    • 2.5.3 Laboratory Corporation of America Holdings Hereditary Disease Testing Product and Solutions
    • 2.5.4 Laboratory Corporation of America Holdings Hereditary Disease Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Laboratory Corporation of America Holdings Recent Developments and Future Plans
  • 2.6 F. Hoffmann-La Roche
    • 2.6.1 F. Hoffmann-La Roche Details
    • 2.6.2 F. Hoffmann-La Roche Major Business
    • 2.6.3 F. Hoffmann-La Roche Hereditary Disease Testing Product and Solutions
    • 2.6.4 F. Hoffmann-La Roche Hereditary Disease Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 F. Hoffmann-La Roche Recent Developments and Future Plans
  • 2.7 Quest Diagnostics
    • 2.7.1 Quest Diagnostics Details
    • 2.7.2 Quest Diagnostics Major Business
    • 2.7.3 Quest Diagnostics Hereditary Disease Testing Product and Solutions
    • 2.7.4 Quest Diagnostics Hereditary Disease Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Quest Diagnostics Recent Developments and Future Plans
  • 2.8 CooperSurgical
    • 2.8.1 CooperSurgical Details
    • 2.8.2 CooperSurgical Major Business
    • 2.8.3 CooperSurgical Hereditary Disease Testing Product and Solutions
    • 2.8.4 CooperSurgical Hereditary Disease Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 CooperSurgical Recent Developments and Future Plans
  • 2.9 Agilent Technologies
    • 2.9.1 Agilent Technologies Details
    • 2.9.2 Agilent Technologies Major Business
    • 2.9.3 Agilent Technologies Hereditary Disease Testing Product and Solutions
    • 2.9.4 Agilent Technologies Hereditary Disease Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Agilent Technologies Recent Developments and Future Plans
  • 2.10 Thermo Fisher Scientific
    • 2.10.1 Thermo Fisher Scientific Details
    • 2.10.2 Thermo Fisher Scientific Major Business
    • 2.10.3 Thermo Fisher Scientific Hereditary Disease Testing Product and Solutions
    • 2.10.4 Thermo Fisher Scientific Hereditary Disease Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Thermo Fisher Scientific Recent Developments and Future Plans
  • 2.11 Twist Bioscience
    • 2.11.1 Twist Bioscience Details
    • 2.11.2 Twist Bioscience Major Business
    • 2.11.3 Twist Bioscience Hereditary Disease Testing Product and Solutions
    • 2.11.4 Twist Bioscience Hereditary Disease Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Twist Bioscience Recent Developments and Future Plans
  • 2.12 Sophia Genetics
    • 2.12.1 Sophia Genetics Details
    • 2.12.2 Sophia Genetics Major Business
    • 2.12.3 Sophia Genetics Hereditary Disease Testing Product and Solutions
    • 2.12.4 Sophia Genetics Hereditary Disease Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Sophia Genetics Recent Developments and Future Plans
  • 2.13 Fulgent Genetic
    • 2.13.1 Fulgent Genetic Details
    • 2.13.2 Fulgent Genetic Major Business
    • 2.13.3 Fulgent Genetic Hereditary Disease Testing Product and Solutions
    • 2.13.4 Fulgent Genetic Hereditary Disease Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Fulgent Genetic Recent Developments and Future Plans
  • 2.14 Medgenome
    • 2.14.1 Medgenome Details
    • 2.14.2 Medgenome Major Business
    • 2.14.3 Medgenome Hereditary Disease Testing Product and Solutions
    • 2.14.4 Medgenome Hereditary Disease Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Medgenome Recent Developments and Future Plans
  • 2.15 CENTOGENE
    • 2.15.1 CENTOGENE Details
    • 2.15.2 CENTOGENE Major Business
    • 2.15.3 CENTOGENE Hereditary Disease Testing Product and Solutions
    • 2.15.4 CENTOGENE Hereditary Disease Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 CENTOGENE Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Hereditary Disease Testing Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Hereditary Disease Testing by Company Revenue
    • 3.2.2 Top 3 Hereditary Disease Testing Players Market Share in 2025
    • 3.2.3 Top 6 Hereditary Disease Testing Players Market Share in 2025
  • 3.3 Hereditary Disease Testing Market: Overall Company Footprint Analysis
    • 3.3.1 Hereditary Disease Testing Market: Region Footprint
    • 3.3.2 Hereditary Disease Testing Market: Company Product Type Footprint
    • 3.3.3 Hereditary Disease Testing Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Hereditary Disease Testing Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Hereditary Disease Testing Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Hereditary Disease Testing Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Hereditary Disease Testing Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Hereditary Disease Testing Consumption Value by Type (2021-2032)
  • 6.2 North America Hereditary Disease Testing Market Size by Application (2021-2032)
  • 6.3 North America Hereditary Disease Testing Market Size by Country
    • 6.3.1 North America Hereditary Disease Testing Consumption Value by Country (2021-2032)
    • 6.3.2 United States Hereditary Disease Testing Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Hereditary Disease Testing Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Hereditary Disease Testing Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Hereditary Disease Testing Consumption Value by Type (2021-2032)
  • 7.2 Europe Hereditary Disease Testing Consumption Value by Application (2021-2032)
  • 7.3 Europe Hereditary Disease Testing Market Size by Country
    • 7.3.1 Europe Hereditary Disease Testing Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Hereditary Disease Testing Market Size and Forecast (2021-2032)
    • 7.3.3 France Hereditary Disease Testing Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Hereditary Disease Testing Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Hereditary Disease Testing Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Hereditary Disease Testing Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Hereditary Disease Testing Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Hereditary Disease Testing Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Hereditary Disease Testing Market Size by Region
    • 8.3.1 Asia-Pacific Hereditary Disease Testing Consumption Value by Region (2021-2032)
    • 8.3.2 China Hereditary Disease Testing Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Hereditary Disease Testing Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Hereditary Disease Testing Market Size and Forecast (2021-2032)
    • 8.3.5 India Hereditary Disease Testing Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Hereditary Disease Testing Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Hereditary Disease Testing Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Hereditary Disease Testing Consumption Value by Type (2021-2032)
  • 9.2 South America Hereditary Disease Testing Consumption Value by Application (2021-2032)
  • 9.3 South America Hereditary Disease Testing Market Size by Country
    • 9.3.1 South America Hereditary Disease Testing Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Hereditary Disease Testing Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Hereditary Disease Testing Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Hereditary Disease Testing Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Hereditary Disease Testing Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Hereditary Disease Testing Market Size by Country
    • 10.3.1 Middle East & Africa Hereditary Disease Testing Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Hereditary Disease Testing Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Hereditary Disease Testing Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Hereditary Disease Testing Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Hereditary Disease Testing Market Drivers
  • 11.2 Hereditary Disease Testing Market Restraints
  • 11.3 Hereditary Disease Testing Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Hereditary Disease Testing Industry Chain
  • 12.2 Hereditary Disease Testing Upstream Analysis
  • 12.3 Hereditary Disease Testing Midstream Analysis
  • 12.4 Hereditary Disease Testing Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Hereditary Disease Testing. Industry analysis & Market Report on Hereditary Disease Testing is a syndicated market report, published as Global Hereditary Disease Testing Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Hereditary Disease Testing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report